Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicoll

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Alimentary Pharmacology & Therapeutics|March 3, 2025
Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian PerspectiveNatassia Tan, Christopher Zampogna, Kate Lynch, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Pharmacological chaperone for the structured domain of human prion proteinAndrew J Nicoll, Clare R Trevitt, M Howard Tattum, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Hereditary vascular dementia linked to notch 3 mutations. CADASIL in British familiesN J Thomas, C M Morris, F Scaravilli, et al.
Nature Communications|September 12, 2013
Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicityAndrew J Nicoll, Silvia Panico, Darragh B Freir, et al.
Scientific Reports|July 20, 2021
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosisSim Yee Ong, Tiffany Khoo, Amanda J Nicoll, et al.
Journal of Gastroenterology and Hepatology|October 27, 2016
HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian womenCharles D Warne, Sophie G Zaloumis, Nadine A Bertalli, et al.
Nature Communications|June 10, 2011
Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sitesDarragh B Freir, Andrew J Nicoll, Igor Klyubin, et al.
Journal of Gastroenterology and Hepatology|October 15, 2014
Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year studySophie G Zaloumis, Katrina J Allen, Nadine A Bertalli, et al.
Lancet (London, England)|July 26, 2005
Use of community genetic screening to prevent HFE-associated hereditary haemochromatosisM B Delatycki, K J Allen, A E Nisselle, et al.
Journal of Gastroenterology and Hepatology|February 18, 2024
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapyN M Batt, B Rodrigues, S Bloom, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Alimentary Pharmacology & Therapeutics|March 3, 2025
Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian PerspectiveNatassia Tan, Christopher Zampogna, Kate Lynch, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Pharmacological chaperone for the structured domain of human prion proteinAndrew J Nicoll, Clare R Trevitt, M Howard Tattum, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Hereditary vascular dementia linked to notch 3 mutations. CADASIL in British familiesN J Thomas, C M Morris, F Scaravilli, et al.
Nature Communications|September 12, 2013
Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicityAndrew J Nicoll, Silvia Panico, Darragh B Freir, et al.
Scientific Reports|July 20, 2021
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosisSim Yee Ong, Tiffany Khoo, Amanda J Nicoll, et al.
Journal of Gastroenterology and Hepatology|October 27, 2016
HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian womenCharles D Warne, Sophie G Zaloumis, Nadine A Bertalli, et al.
Nature Communications|June 10, 2011
Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sitesDarragh B Freir, Andrew J Nicoll, Igor Klyubin, et al.
Journal of Gastroenterology and Hepatology|October 15, 2014
Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year studySophie G Zaloumis, Katrina J Allen, Nadine A Bertalli, et al.
Lancet (London, England)|July 26, 2005
Use of community genetic screening to prevent HFE-associated hereditary haemochromatosisM B Delatycki, K J Allen, A E Nisselle, et al.
Journal of Gastroenterology and Hepatology|February 18, 2024
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapyN M Batt, B Rodrigues, S Bloom, et al.
Pageof 13